MDxHealth SA (MDXH)

CIK 0001872529 · Healthcare · Diagnostics and Research

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Statement of Profit Or Loss
—
Consolidated Statement of Profit Or Loss (P)
—
Consolidated Statement of Comprehensive Income
—
Consolidated Statement of Financial Position
—
Consolidated Statement of Changes In Equity
—
Consolidated Statement of Cash Flow
—
Notes
Business Combination
—
Cash and Cash Equivalents
—
Commitments, Contingencies and Other Significant Agreements
—
Contractual Obligations
—
Cybersecurity Risk Management and Strategy Disclosure
—
Financial Income and Expenses
—
Financial Instruments and Fair Value
—
Financial Risk Management
—
Goodwill
—
Income Tax
—
Insider Trading Policies and Procedures
—
Intangible Assets
—
Inventories
—
Loans, Borrowings, Lease Obligations and Other Financial Liabilities
—
Loss Per Share
—
Nature of Expenses
—
Other Operating (expense) Income, Net
—
Personnel Costs
—
Principal Audit Fees and Services
—
Property, Plant and Equipment and Right Of-use Assets
—
Related Parties
—
Retirement Benefit Plans
—
Revenue and Cost of Sales
—
Share Capital and Reserves
—
Share-based Payments
—
Significant Agreements, Commitments and Contingencies
—
Status and Principal Activity
—
Subsequent Events
—
Subsidiaries
—
Summary of Material Accounting Policies
—
Trade and Other Payables
—
Trade and Other Receivables
—
Trade Receivables, Prepaid Expenses and Other Current Assets
—